Brain’s Natural Defense Against Alzheimer’s Uncovered by UCLA and UCSF Researchers

Scientists at UCLA Health and UC San Francisco have identified a natural brain defense mechanism that helps certain neurons withstand the buildup of tau, a toxic protein strongly linked to Alzheimer’s disease and related dementias. The discovery, published in the journal Cell, offers potential new targets for therapies aimed at slowing or preventing the progression of these devastating neurodegenerative conditions.

The Role of Tau and Why Some Neurons Are More Vulnerable

Tau protein is the most common protein to aggregate in neurodegenerative diseases, including Alzheimer’s and frontotemporal dementia. These proteins accumulate as toxic clumps in the brain, ultimately leading to neuronal damage and cell death. However, researchers have long been puzzled as to why some types of neurons are more susceptible to tau buildup than others. This new research begins to answer that question.

CRISPR Screening Reveals a Tau Cleanup System

The research team employed a novel CRISPR-based genetic screening approach using lab-grown human neurons to pinpoint the cellular machinery responsible for controlling tau accumulation. This large-scale screen identified a protein complex called CRL5SOCS4. CRL5SOCS4 functions by tagging tau for degradation, essentially marking it for removal by the cell’s waste disposal system.

“We wanted to understand why some neurons are vulnerable to tau accumulation although others are more resilient,” said Dr. Avi Samelson, assistant professor of Neurology at UCLA Health, who conducted the research while at UCSF. “By systematically screening nearly every gene in the human genome, we found both expected pathways and completely unexpected ones that control tau levels in neurons.”

Findings in Alzheimer’s Disease Brain Tissue

Further investigation revealed that neurons with higher levels of CRL5SOCS4 components were more likely to survive even in the presence of tau accumulation when examining brain tissue from individuals with Alzheimer’s disease. This suggests that bolstering the activity of this natural cleanup pathway could be a promising therapeutic strategy.

Mitochondrial Stress and a Harmful Tau Fragment

The study also uncovered a surprising connection between mitochondrial dysfunction and tau toxicity. Mitochondria are the cell’s powerhouses and when they become stressed, they can produce a specific tau fragment approximately 25 kilodaltons in size. This fragment closely matches a biomarker, known as NTA-tau, detected in the blood and spinal fluid of Alzheimer’s patients.

“This tau fragment appears to be generated when cells experience oxidative stress, which is common in aging and neurodegeneration,” explained Dr. Samelson. “We found that this stress reduces the efficiency of the proteasome, the cell’s protein recycling machine, causing it to improperly process tau.” This improper processing leads to altered tau clustering, potentially influencing disease progression.

Potential Therapeutic Directions

The findings open several avenues for potential Alzheimer’s treatments. Strategies to increase CRL5SOCS4 activity could enhance the brain’s ability to clear tau. Simultaneously, protecting the proteasome during periods of cellular stress could minimize the formation of these harmful tau fragments.

“What makes this study particularly valuable is that we used human neurons carrying an actual disease-causing mutation,” Dr. Samelson noted. “These cells naturally have differences in tau processing, giving us confidence that the mechanisms we identified are relevant to human disease.”

Beyond CRL5SOCS4: Additional Pathways Identified

The comprehensive genetic screen also revealed other biological pathways not previously linked to tau regulation, including UFMylation (a protein modification process) and enzymes involved in building membrane anchors within cells. These discoveries provide further targets for future research.

Looking Ahead

While these results are encouraging, researchers emphasize that further investigation is necessary before these discoveries can be translated into effective treatments. The study was funded by the Rainwater Charitable Foundation/Tau Consortium, the National Institutes of Health, and other sources. This research represents a significant step forward in understanding the complex mechanisms underlying Alzheimer’s disease and offers hope for the development of new therapies to combat this growing global health challenge.